SK280081B6 - Transdermálny terapeutický systém a spôsob jeho vý - Google Patents
Transdermálny terapeutický systém a spôsob jeho vý Download PDFInfo
- Publication number
- SK280081B6 SK280081B6 SK1468-94A SK146894A SK280081B6 SK 280081 B6 SK280081 B6 SK 280081B6 SK 146894 A SK146894 A SK 146894A SK 280081 B6 SK280081 B6 SK 280081B6
- Authority
- SK
- Slovakia
- Prior art keywords
- estradiol
- layer
- transdermal therapeutic
- therapeutic system
- matrix
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4223360A DE4223360C1 (cs) | 1992-07-16 | 1992-07-16 | |
PCT/EP1993/001754 WO1994002151A1 (de) | 1992-07-16 | 1993-07-07 | TRANSDERMALES THERAPEUTISCHES SYSTEM MIT DEM WIRKSTOFF 17-β-ESTRADIOL (WASSERFREI) |
Publications (2)
Publication Number | Publication Date |
---|---|
SK146894A3 SK146894A3 (en) | 1996-01-10 |
SK280081B6 true SK280081B6 (sk) | 1999-07-12 |
Family
ID=6463319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1468-94A SK280081B6 (sk) | 1992-07-16 | 1993-07-07 | Transdermálny terapeutický systém a spôsob jeho vý |
Country Status (24)
Country | Link |
---|---|
US (1) | US5997897A (cs) |
EP (1) | EP0650359B1 (cs) |
JP (1) | JP3227577B2 (cs) |
KR (1) | KR100281235B1 (cs) |
AT (1) | ATE179328T1 (cs) |
AU (1) | AU679450B2 (cs) |
CA (1) | CA2139929C (cs) |
CZ (1) | CZ283501B6 (cs) |
DE (2) | DE4223360C1 (cs) |
DK (1) | DK0650359T3 (cs) |
ES (1) | ES2133405T3 (cs) |
FI (1) | FI950165A (cs) |
GR (1) | GR3030807T3 (cs) |
HR (1) | HRP930991B1 (cs) |
HU (1) | HU221011B1 (cs) |
IL (1) | IL106315A (cs) |
MY (1) | MY111688A (cs) |
NO (1) | NO306378B1 (cs) |
NZ (1) | NZ254107A (cs) |
PL (1) | PL172466B1 (cs) |
SI (1) | SI9300387B (cs) |
SK (1) | SK280081B6 (cs) |
WO (1) | WO1994002151A1 (cs) |
ZA (1) | ZA935107B (cs) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1043731C (zh) * | 1993-03-05 | 1999-06-23 | 中国人民解放军空军南京医院 | 治疗高血压的尼群地平贴片及其制备方法 |
DE4336557C2 (de) * | 1993-05-06 | 1997-07-17 | Lohmann Therapie Syst Lts | Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
DE4400770C1 (de) * | 1994-01-13 | 1995-02-02 | Lohmann Therapie Syst Lts | Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung |
DE4429664C2 (de) * | 1994-08-20 | 1997-09-11 | Lohmann Therapie Syst Lts | Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung |
WO1997020550A2 (en) * | 1995-12-01 | 1997-06-12 | Alza Corporation | Improved method for preventing crystal formation in a dispersion of a liquid in a matrix |
US6238700B1 (en) | 1995-12-01 | 2001-05-29 | Alza Corporation | Method for preventing crystal formation in a dispersion of a liquid in a matrix |
DE19600347A1 (de) * | 1996-01-08 | 1997-07-10 | Lohmann Therapie Syst Lts | Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus |
DE19738856C2 (de) * | 1997-09-05 | 2001-06-13 | Lohmann Therapie Syst Lts | Treibmittelfreies Verfahren zur Herstellung flächenförmiger Polymerschäume |
DE19827732A1 (de) * | 1998-06-22 | 1999-12-23 | Rottapharm Bv | Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie |
AU760404B2 (en) * | 2000-07-14 | 2003-05-15 | Alchemia Oncology Pty Limited | Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease |
AR033748A1 (es) * | 2002-05-15 | 2004-01-07 | Thalas Group Inc | Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo |
US8343538B2 (en) * | 2004-10-08 | 2013-01-01 | Noven Pharmaceuticals, Inc. | Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems |
US20060127463A1 (en) * | 2004-12-15 | 2006-06-15 | Nugara Peter N | Composite structure including a low vinyl acetate layer |
CA2891537C (en) | 2012-11-26 | 2021-02-02 | Ocv Intellectual Capital, Llc | Multi-axial fabrics, polymer-fiber laminates, and bodies incorporating same for connecting applications |
PL236889B1 (pl) * | 2017-10-03 | 2021-02-22 | Univ Warszawski Medyczny | Nowa forma krystaliczna bezwodnego 17-β-estradiolu, sposób jej otrzymywania oraz kompozycja farmaceutyczna zawierająca nową formę krystaliczną bezwodnego 17-β-estradiolu i jej zastosowanie |
HUP2200237A2 (hu) * | 2022-06-27 | 2023-12-28 | Pecsi Tudomanyegyetem | Alacsony dózisú, stabil hatóanyag-leadású transzdermális készítmény és tapasz, valamint eljárás ezek elõállítására |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3854480A (en) * | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
US5145682A (en) * | 1986-05-30 | 1992-09-08 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration |
US4832953A (en) * | 1987-08-13 | 1989-05-23 | Alza Corporation | Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix |
US4863738A (en) * | 1987-11-23 | 1989-09-05 | Alza Corporation | Skin permeation enhancer compositions using glycerol monooleate |
JP2681365B2 (ja) * | 1988-04-11 | 1997-11-26 | 日東電工株式会社 | 経皮吸収性製剤及びその製法 |
JPH0279792A (ja) * | 1988-09-12 | 1990-03-20 | Secoh Giken Inc | 高速3相直流電動機 |
DE3933460A1 (de) * | 1989-10-06 | 1991-04-18 | Lohmann Therapie Syst Lts | Oestrogenhaltiges wirkstoffpflaster |
-
1992
- 1992-07-16 DE DE4223360A patent/DE4223360C1/de not_active Expired - Fee Related
-
1993
- 1993-05-21 MY MYPI93000967A patent/MY111688A/en unknown
- 1993-06-23 HR HRP4223360.7A patent/HRP930991B1/xx not_active IP Right Cessation
- 1993-07-07 AU AU45650/93A patent/AU679450B2/en not_active Ceased
- 1993-07-07 DE DE59309549T patent/DE59309549D1/de not_active Expired - Lifetime
- 1993-07-07 DK DK93915819T patent/DK0650359T3/da active
- 1993-07-07 SK SK1468-94A patent/SK280081B6/sk unknown
- 1993-07-07 KR KR1019950700166A patent/KR100281235B1/ko not_active IP Right Cessation
- 1993-07-07 AT AT93915819T patent/ATE179328T1/de active
- 1993-07-07 EP EP93915819A patent/EP0650359B1/de not_active Expired - Lifetime
- 1993-07-07 CA CA002139929A patent/CA2139929C/en not_active Expired - Lifetime
- 1993-07-07 NZ NZ254107A patent/NZ254107A/en unknown
- 1993-07-07 JP JP50390894A patent/JP3227577B2/ja not_active Expired - Lifetime
- 1993-07-07 HU HU9403474A patent/HU221011B1/hu not_active IP Right Cessation
- 1993-07-07 CZ CZ95106A patent/CZ283501B6/cs not_active IP Right Cessation
- 1993-07-07 ES ES93915819T patent/ES2133405T3/es not_active Expired - Lifetime
- 1993-07-07 WO PCT/EP1993/001754 patent/WO1994002151A1/de active IP Right Grant
- 1993-07-07 PL PL93306557A patent/PL172466B1/pl unknown
- 1993-07-12 IL IL10631593A patent/IL106315A/en not_active IP Right Cessation
- 1993-07-15 ZA ZA935107A patent/ZA935107B/xx unknown
- 1993-07-16 SI SI9300387A patent/SI9300387B/sl unknown
-
1995
- 1995-01-05 NO NO950047A patent/NO306378B1/no not_active IP Right Cessation
- 1995-01-13 FI FI950165A patent/FI950165A/fi unknown
-
1998
- 1998-08-14 US US09/134,007 patent/US5997897A/en not_active Expired - Lifetime
-
1999
- 1999-07-20 GR GR990401895T patent/GR3030807T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5830505A (en) | Active ingredient patch | |
FI103478B (fi) | Menetelmä transdermaalisen terapeuttisen järjestelmän valmistamiseksi, jossa vaikuttavan aineen virtausta on suurennettu | |
SK280081B6 (sk) | Transdermálny terapeutický systém a spôsob jeho vý | |
SK58095A3 (en) | Transdermal therapeutic system for dosing of 17-beta-estradiol and process for its production | |
CZ290324B6 (cs) | Transdermální terapeutický systém a způsob jeho výroby | |
BR112014016176B1 (pt) | Sistema terapêutico transdérmico com uma baixa tendência de cristalização espontânea e método para a formação do mesmo | |
AU709288B2 (en) | Transdermal therapeutic system (tts) for the administration of drugs for treatment of drug dependency or drug addiction | |
CZ75797A3 (en) | Transdermal therapeutic system having the form of an adhesive plaster | |
FI118720B (fi) | Estradioli-TTS, jossa on vettä sitovia lisäaineita | |
US5827245A (en) | Transdermal therapeutic system comprising the active subtance 17-β-Estradiol (Anhydrous) | |
KR100476579B1 (ko) | 17-β-에스트라디올을인체로방출하기위한피부접착용약제 | |
SK278438B6 (en) | The composition for transdermal application with gestodene content | |
KR20130114127A (ko) | 결정화-억제 보호 필름 (이형 라이너)을 사용하는 경피 치료 시스템 | |
CA2172401C (en) | Transdermal therapeutic system with acetylsalicylic acid as active substance |